InsiderTrades.com logo

BHVN Insider Trading

Insider Ownership Percentage: 16.00%
Insider Buying (Last 12 Months): $13,273,971.54
Insider Selling (Last 12 Months): $0.00

Biohaven Insider Trading History Chart

This chart shows the insider buying and selling history at Biohaven by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biohaven Share Price & Price History

Current Price: $41.45
Price Change: ▼ Price Decrease of -0.342 (-0.82%)
As of 02/14/2025 04:59 PM ET

This chart shows the closing price history over time for BHVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Biohaven Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/30/2024John W. ChildsDirectorBuy29,000$35.94$1,042,260.002,368,741View SEC Filing Icon  
10/2/2024John W. ChildsDirectorBuy21,052$47.50$999,970.0021,052View SEC Filing Icon  
9/24/2024Gregory H. BaileyDirectorBuy5,000$44.19$220,950.001,620,071View SEC Filing Icon  
7/18/2024John W. ChildsDirectorBuy28,400$35.67$1,013,028.002,339,741View SEC Filing Icon  
5/30/2024John W. ChildsDirectorBuy28,000$35.58$996,240.002,311,341View SEC Filing Icon  
5/13/2024John W. ChildsDirectorBuy28,500$35.17$1,002,345.002,283,341View SEC Filing Icon  
4/24/2024Gregory H. BaileyDirectorBuy25,503$39.18$999,207.541,600,071View SEC Filing Icon  
4/22/2024Gregory H. BaileyDirectorBuy48,780$41.00$1,999,980.001,574,568View SEC Filing Icon  
4/22/2024Vlad CoricCEOBuy121,951$41.00$4,999,991.001,788,417View SEC Filing Icon  
12/29/2023Irina AntonijevicDirectorSell11,000$41.79$459,690.002,535View SEC Filing Icon  
10/5/2023Matthew ButenCFOBuy22,727$22.00$499,994.00189,380View SEC Filing Icon  
10/5/2023Vlad CoricCEOBuy113,637$22.00$2,500,014.001,657,031View SEC Filing Icon  
10/4/2023Gregory H. BaileyDirectorBuy17,817$22.57$402,129.691,525,788View SEC Filing Icon  
8/30/2023John W. ChildsDirectorBuy50,000$18.44$922,000.001,975,118View SEC Filing Icon  
8/4/2023John W. ChildsDirectorBuy100,000$19.78$1,978,000.001,925,118View SEC Filing Icon  
10/31/2022Vlad CoricCEOBuy25,800$15.97$412,026.001,543,394View SEC Filing Icon  
10/28/2022Vlad CoricCEOBuy41,930$14.87$623,499.101,517,594View SEC Filing Icon  
10/25/2022Gregory H. BaileyDirectorBuy200,000$10.50$2,100,000.001,507,971View SEC Filing Icon  
10/25/2022Matthew ButenCFOBuy142,857$10.50$1,499,998.50166,653View SEC Filing Icon  
10/25/2022Vlad CoricCEOBuy853,380$10.50$8,960,490.001,475,664View SEC Filing Icon  
8/19/2022Gregory H. BaileyDirectorBuy38,000$148.04$5,625,520.002,583,658View SEC Filing Icon  
5/10/2022George C. ClarkCAOSell4,200$141.50$594,300.004,065View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Biohaven (NYSE:BHVN)

88.78% of Biohaven stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BHVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Biohaven Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC548,575$20.49M0.0%+7.9%0.542%Search for SEC Filing on Google Icon
2/17/2025Voloridge Investment Management LLC100,568$3.76M0.0%-62.2%0.099%Search for SEC Filing on Google Icon
2/17/2025Woodline Partners LP601,922$22.48M0.2%-34.8%0.595%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP99,900$3.73M0.0%-45.8%0.099%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP80,863$3.02M0.0%-71.2%0.080%Search for SEC Filing on Google Icon
2/17/2025TrinityPoint Wealth LLC37,095$1.39M0.2%N/A0.037%Search for SEC Filing on Google Icon
2/17/2025Stempoint Capital LP186,413$6.96M1.7%-13.9%0.184%Search for SEC Filing on Google Icon
2/17/2025Suvretta Capital Management LLC5,620,271$209.92M7.2%+8.1%5.558%Search for SEC Filing on Google Icon
2/17/2025Sphera Funds Management LTD.156,494$5.85M1.1%+17.4%0.155%Search for SEC Filing on Google Icon
2/17/2025Rafferty Asset Management LLC135,256$5.05M0.0%-1.7%0.134%Search for SEC Filing on Google Icon
2/17/2025Redmile Group LLC904,496$33.78M2.4%-12.5%0.894%Search for SEC Filing on Google Icon
2/17/2025Point72 Asset Management L.P.922,965$34.47M0.1%-38.5%0.913%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC24,189$0.90M0.0%+70.5%0.024%Search for SEC Filing on Google Icon
2/17/2025Nicholas Investment Partners LP18,673$0.70M0.1%-26.6%0.018%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC919,235$34.33M0.0%+55.1%0.909%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.54,271$2.02M0.0%+32.0%0.054%Search for SEC Filing on Google Icon
2/17/2025Lazard Asset Management LLC3,207$0.12M0.0%+47.4%0.003%Search for SEC Filing on Google Icon
2/17/2025Lion Point Capital LP22,700$0.85M4.4%-35.9%0.022%Search for SEC Filing on Google Icon
2/17/2025Janus Henderson Group PLC6,982,425$260.74M0.1%+12.1%6.905%Search for SEC Filing on Google Icon
2/17/2025Farallon Capital Management LLC4,428,167$165.39M0.8%+21.6%4.379%Search for SEC Filing on Google Icon
2/17/2025Fred Alger Management LLC104,567$3.91M0.0%+79.8%0.103%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.170,647$6.37M0.0%-70.5%0.169%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG169,773$6.34M0.0%+25.0%0.168%Search for SEC Filing on Google Icon
2/17/2025DAFNA Capital Management LLC220,235$8.23M2.1%+17.7%0.218%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC23,671$0.88M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/17/2025Boone Capital Management LLC361,420$13.50M4.6%N/A0.357%Search for SEC Filing on Google Icon
2/17/2025Brown Advisory Inc.975,585$36.44M0.0%+0.7%0.965%Search for SEC Filing on Google Icon
2/17/2025Bamco Inc. NY44,000$1.64M0.0%-2.2%0.044%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE310,559$11.60M0.0%+40.5%0.307%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets41,762$1.56M0.0%N/A0.041%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.508,682$18.99M0.0%+40.0%0.503%Search for SEC Filing on Google Icon
2/17/2025Algert Global LLC31,320$1.17M0.0%-3.3%0.031%Search for SEC Filing on Google Icon
2/17/2025Alyeska Investment Group L.P.106,351$3.97M0.0%+129.4%0.105%Search for SEC Filing on Google Icon
2/14/2025Bison Wealth LLC332,428$12.42M2.7%+0.4%0.329%Search for SEC Filing on Google Icon
2/14/2025Emerald Mutual Fund Advisers Trust226,394$8.46M0.5%N/A0.224%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp811,155$30.30M0.0%+19.9%0.802%Search for SEC Filing on Google Icon
2/14/2025The Manufacturers Life Insurance Company 199,183$7.44M0.0%+3.4%0.197%Search for SEC Filing on Google Icon
2/14/2025Quarry LP3,000$0.11M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/14/2025Tri Locum Partners LP140,220$5.24M1.1%-27.4%0.139%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC1,770$66K0.0%-35.9%0.002%Search for SEC Filing on Google Icon
2/14/2025Voya Investment Management LLC713,587$26.65M0.0%-0.8%0.706%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.575,000$21.48M0.0%-61.2%0.569%Search for SEC Filing on Google Icon
2/14/2025Hood River Capital Management LLC783,672$29.27M0.4%-13.2%0.775%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD3,412,191$127.45M0.0%-0.8%3.374%Search for SEC Filing on Google Icon
2/14/2025Hsbc Holdings PLC10,361$0.38M0.0%+10.8%0.010%Search for SEC Filing on Google Icon
2/14/2025Rock Springs Capital Management LP129,858$4.85M0.2%+1.8%0.128%Search for SEC Filing on Google Icon
2/14/2025Stifel Financial Corp6,559,313$244.99M0.3%+0.8%6.487%Search for SEC Filing on Google Icon
2/14/2025Tower Research Capital LLC TRC 12,180$0.46M0.0%+2,952.6%0.012%Search for SEC Filing on Google Icon
2/14/2025Transatlantique Private Wealth LLC13,431$0.50M0.2%-5.0%0.013%Search for SEC Filing on Google Icon
2/14/2025MYDA Advisors LLC54,000$2.02M0.5%-22.9%0.053%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC51,737$1.93M0.0%+19.0%0.051%Search for SEC Filing on Google Icon
2/14/2025Altium Capital Management LLC250,000$9.34M2.6%+233.3%0.247%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP366,891$13.70M0.0%-1.3%0.363%Search for SEC Filing on Google Icon
2/13/2025Gabelli Funds LLC9,000$0.34M0.0%-31.8%0.009%Search for SEC Filing on Google Icon
2/13/2025Elkhorn Partners Limited Partnership3,300$0.12M0.1%+50.0%0.003%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC392,727$14.67M0.0%+46.5%0.388%Search for SEC Filing on Google Icon
2/13/2025Summit Investment Advisors Inc.8,985$0.34M0.3%+18.1%0.009%Search for SEC Filing on Google Icon
2/13/2025Neuberger Berman Group LLC129,465$4.84M0.0%+2,953.4%0.128%Search for SEC Filing on Google Icon
2/13/2025Capital Fund Management S.A.38,488$1.44M0.0%+130.1%0.038%Search for SEC Filing on Google Icon
2/13/2025F M Investments LLC26,338$0.98M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/13/2025Raymond James Financial Inc.37,033$1.38M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC19,352$0.72M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/13/2025FIL Ltd89,391$3.34M0.0%+4.9%0.088%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc90,847$3.39M0.0%+5.1%0.090%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.51,814$1.94M0.0%+6.2%0.051%Search for SEC Filing on Google Icon
2/13/2025Federated Hermes Inc.12,753$0.48M0.0%-41.0%0.013%Search for SEC Filing on Google Icon
2/13/2025Russell Investments Group Ltd.146,125$5.46M0.0%-10.3%0.145%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN43,650$1.63M0.0%+30.6%0.043%Search for SEC Filing on Google Icon
2/12/2025Landscape Capital Management L.L.C.18,710$0.70M0.1%N/A0.019%Search for SEC Filing on Google Icon
2/12/2025Bryce Point Capital LLC32,000$1.20M0.3%N/A0.032%Search for SEC Filing on Google Icon
2/12/2025Trexquant Investment LP10,980$0.41M0.0%-41.5%0.011%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC1,905,366$71.18M0.0%+11.1%1.884%Search for SEC Filing on Google Icon
2/12/2025Franklin Resources Inc.74,300$2.78M0.0%-6.8%0.073%Search for SEC Filing on Google Icon
2/12/2025Alliancebernstein L.P.96,236$3.59M0.0%+6.6%0.095%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP634,055$23.68M0.0%+160.7%0.627%Search for SEC Filing on Google Icon
2/12/2025O Shaughnessy Asset Management LLC9,777$0.37M0.0%-2.7%0.010%Search for SEC Filing on Google Icon
2/12/2025Clearbridge Investments LLC521,099$19.46M0.0%+8.7%0.515%Search for SEC Filing on Google Icon
2/12/2025CIBC Private Wealth Group LLC790$31K0.0%-39.5%0.001%Search for SEC Filing on Google Icon
2/12/2025RWA Wealth Partners LLC11,800$0.44M0.0%+81.5%0.012%Search for SEC Filing on Google Icon
2/12/2025DnB Asset Management AS7,526$0.28M0.0%+8.2%0.007%Search for SEC Filing on Google Icon
2/12/2025Pictet Asset Management Holding SA405,848$15.16M0.0%+32.2%0.401%Search for SEC Filing on Google Icon
2/12/2025Norges Bank902,565$33.71M0.0%N/A0.893%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.1,979,169$73.92M0.0%+144.5%1.957%Search for SEC Filing on Google Icon
2/11/2025EFG Asset Management North America Corp.56,713$2.12M0.3%N/A0.056%Search for SEC Filing on Google Icon
2/11/2025Prudential Financial Inc.5,980$0.22M0.0%+9.4%0.006%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.42,701$1.60M0.0%+6.4%0.042%Search for SEC Filing on Google Icon
2/11/2025Emerald Advisers LLC360,538$13.47M0.5%N/A0.357%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.8,414,120$314.27M0.0%+8.1%8.321%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC42,190$1.58M0.0%+4.1%0.042%Search for SEC Filing on Google Icon
2/11/2025Fox Run Management L.L.C.5,611$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS16,100$0.60M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/11/2025Sei Investments Co.69,082$2.58M0.0%+55.7%0.068%Search for SEC Filing on Google Icon
2/11/2025American Century Companies Inc.558,761$20.87M0.0%+9.5%0.553%Search for SEC Filing on Google Icon
2/11/2025Quantbot Technologies LP9,508$0.36M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/11/2025DCF Advisers LLC36,000$1.35M0.7%+16.1%0.036%Search for SEC Filing on Google Icon
2/11/2025Magnetar Financial LLC39,260$1.47M0.0%+498.7%0.039%Search for SEC Filing on Google Icon
2/11/2025Teacher Retirement System of Texas23,320$0.87M0.0%+31.6%0.023%Search for SEC Filing on Google Icon
2/11/2025Xponance Inc.6,148$0.23M0.0%+25.9%0.006%Search for SEC Filing on Google Icon
2/11/2025Intech Investment Management LLC34,165$1.28M0.0%+202.2%0.034%Search for SEC Filing on Google Icon
2/10/2025Cibc World Markets Corp8,037$0.30M0.0%N/A0.008%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Biohaven logo
Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company's pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors; Taldefgrobep Alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 2/3 clinical trials for the treatment of focal and generalized epilepsy, bipolar disorder, and major depressive disorder; BHV-2100 that is in Phase 1 clinical trials for the treatment of migraines and neuropathic pain; and BHV-8000, a product candidate in Phase 1 clinical trials for the treatment of early Alzheimer's and Parkinson's disease, sclerosis, and amyloid-related imaging abnormalities. It also offers BHV-1300, a product candidate in Phase 1 clinical trials to treat rheumatoid arthritis; BHV-1310 for the treatment of generalized myasthenia gravis and acute exacerbations or flares; BHV-1400 to treat IgA Nephropathy; and BHV-1600 for the treatment of dilated cardiomyopathy. In addition, the company develops BHV-1100, a product candidate in Phase 1a/1b clinical trials for multiple myeloma patients; BHV-1510, a preclinical product that targets carcinomas; and BHV-1500 for Hodgkin's lymphoma. It has license, development, and commercialization agreements with Yale University, AstraZeneca, University of Connecticut, Artizan Biosciences Inc., Reliant Glycosciences LLC, Katholieke Universiteit Leuven, BMS, and Highlightll Pharmaceutical Co. Ltd. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
Read More on Biohaven

Today's Range

Now: $41.45
Low: $41.22
High: $42.82

50 Day Range

MA: $38.53
Low: $35.34
High: $42.79

52 Week Range

Now: $41.45
Low: $26.80
High: $62.21

Volume

480,365 shs

Average Volume

842,000 shs

Market Capitalization

$4.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of Biohaven?

Biohaven's top insider shareholders include:
  1. John W Childs (Director)
  2. Vlad Coric (CEO)
  3. Gregory Bailey (Director)
  4. Matthew Buten (CFO)
  5. Irina Antonijevic (Director)
Learn More about top insider investors at Biohaven.

Who are the major institutional investors of Biohaven?

Biohaven's top institutional shareholders include:
  1. Vanguard Group Inc. — 8.32%
  2. Janus Henderson Group PLC — 6.91%
  3. Stifel Financial Corp — 6.49%
  4. Suvretta Capital Management LLC — 5.56%
  5. Farallon Capital Management LLC — 4.38%
  6. Price T Rowe Associates Inc. MD — 3.37%
Learn More about top institutional investors of Biohaven stock.

Which major investors are selling Biohaven stock?

During the last quarter, BHVN stock was sold by these institutional investors:
  1. Adage Capital Partners GP L.L.C.
  2. Point72 Asset Management L.P.
  3. D. E. Shaw & Co. Inc.
  4. Woodline Partners LP
  5. Two Sigma Investments LP
  6. Voloridge Investment Management LLC
  7. Redmile Group LLC
  8. Hood River Capital Management LLC

Which major investors are buying Biohaven stock?

During the last quarter, BHVN stock was bought by institutional investors including:
  1. JPMorgan Chase & Co.
  2. Norges Bank
  3. Farallon Capital Management LLC
  4. Janus Henderson Group PLC
  5. Vanguard Group Inc.
  6. Suvretta Capital Management LLC
  7. Wellington Management Group LLP
  8. Boone Capital Management LLC
Within the previous year, these company insiders have bought Biohaven stock:
  1. John W Childs (Director)
  2. Vlad Coric (CEO)
  3. Gregory Bailey (Director)
  4. Matthew Buten (CFO)
Learn More investors buying Biohaven stock.